Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.03 (-5.26%)
Close on Nov 18, 2026Market cap $3.25MP/E –Yield –
Imunon net income
Net income is the profit left for shareholders after every expense, interest and tax.
Imunon's net income for the twelve months ending Mar 31, 2026 was -$14.64M. For fiscal 2025 it was -$14.50M. The highest annual figure on record is -$8.25M in fiscal 2013.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.50M | – |
| FY2024 | Dec 31, 2024 | -$18.62M | – |
| FY2023 | Dec 31, 2023 | -$19.51M | – |
| FY2022 | Dec 31, 2022 | -$35.90M | – |
| FY2021 | Dec 31, 2021 | -$20.77M | – |
| FY2020 | Dec 31, 2020 | -$21.48M | – |
| FY2019 | Dec 31, 2019 | -$16.85M | – |
| FY2018 | Dec 31, 2018 | -$11.88M | – |
| FY2017 | Dec 31, 2017 | -$20.40M | – |
| FY2016 | Dec 31, 2016 | -$22.05M | – |
| FY2015 | Dec 31, 2015 | -$22.46M | – |
| FY2014 | Dec 31, 2014 | -$25.49M | – |
| FY2013 | Dec 31, 2013 | -$8.25M | – |
| FY2012 | Dec 31, 2012 | -$26.57M | – |
| FY2011 | Dec 31, 2011 | -$23.22M | – |
| FY2010 | Dec 31, 2010 | -$18.82M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$4.25M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.22M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.85M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.79M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.93M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.89M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.48M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.23M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.15M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.04M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.47M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.22M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.41M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.45M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.01M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.07M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.06M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.10M | -156.6% |
| Q3 FY2019 | Sep 30, 2019 | -$5.48M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.37M | – |
| Q4 FY2018 | Dec 31, 2018 | $5.48M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.66M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.23M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.48M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.68M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.67M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.67M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.16M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.40M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.41M | – |
| Q2 FY2016 | Jun 30, 2016 | -$4.53M | – |
| Q1 FY2016 | Mar 31, 2016 | -$5.72M | – |
See a number that looks wrong?